Home

Joseph Ciaffoni

CIK 1443841 · Chief Executive Officer · last filed 2026-06-23

Joseph Ciaffoni is a Chief Executive Officer who has filed 61 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for INDV, was dated Jun 23, 2026. Across all open-market trades the lifetime net is −$16.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $38.5M across reported positions. 2 SEC filings were submitted jointly with Endo International plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$38.50M

Companies

4

Total Filings

61

Lifetime Open-Market Net

-$16.93M

Filer Profile

Reported Address
10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, VA 23235
Related Filers
Endo International plc — 2 joint filings, latest 2016-08-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INDV Chief Executive Officer 790,330 $35.99 $28.44M $0 2 2026-06-23
COLL President and CEO 444,867 $22.60 $10.05M -$14.98M 33 2024-02-14
COLLEGIUM PHARMACEUTICAL, INC (ESPR) Delisted President and CEO 177,455 $3.18 $564.3K -$1.95M 10 2019-08-13
Endo International plc (ENDP) Delisted President, U.S. Branded Pharma 17,452 $0.29 $5.1K $0 1 2016-08-18

Recent Filings

61 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-23 INDV Mixed +654,354 -$23.47M EDGAR
2026-02-12 INDV Grant (A) +79,976 $0 EDGAR
2024-06-05 COLL Notice (144) −131,196 -$4.16M EDGAR
2024-06-04 COLL Notice (144) −84,313 -$2.66M EDGAR
2024-06-03 COLL Notice (144) −52,572 -$1.71M EDGAR
2024-05-30 COLL Notice (144) −54,147 -$1.79M EDGAR
2024-05-29 COLL Notice (144/A) −54,146 -$1.84M EDGAR
2024-05-29 COLL Notice (144) −54,146 -$1.84M EDGAR
2024-05-28 COLL Notice (144) −48,992 -$1.68M EDGAR
2024-02-14 COLL Mixed +169,867 -$4.34M EDGAR
Showing 1–10 of 61
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.